FLYER: Four cycles of R-CHOP as good as six in low-risk DLBCLDecember 1, 2018Lymphoma & Plasma Cell Disorders
FLYER: R-CHOP 4 safer, as effective for low-risk DLBCL patients under 60December 1, 2018Lymphoma & Plasma Cell Disorders
Bortezomib may unlock resistance in WM with mutationsNovember 15, 2018Lymphoma & Plasma Cell Disorders
Will quad therapy become the new standard in myeloma?October 2, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Real-world clues for optimal sequencing of CLL novel agentsSeptember 25, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Outpatient lenalidomide/rituximab yields long-term MCL remissionSeptember 25, 2018Lymphoma & Plasma Cell Disorders
Implementation of Chemo and Anti-Neoplastic Extractor Cycle and Regimen Estimator (Cancer Care) in Follicular Lymphoma Patients Treated in VASeptember 17, 2018Lymphoma & Plasma Cell Disorders
STORM trial shows response in penta-refractory myelomaSeptember 16, 2018Multiple MyelomaLymphoma & Plasma Cell DisordersOncologyHematology
Pruritus linked to wide variety of cancersSeptember 16, 2018AMLLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Evaluation of Acute Toxicity in Treating Pelvic Lymph Nodes With Prostate Boost With Hypofractionated Simultaneous Integrated Boost (SIB) Using Volumetric Arc Therapy (VMAT)September 14, 2018Lymphoma & Plasma Cell Disorders
A Case of Systemic Mastocytosis With Associated Clonal Hematological Non-Mast Cell Lineage Disease at VA Pittsburgh Healthcare SystemSeptember 14, 2018Lymphoma & Plasma Cell Disorders
Translocation T(11;14): Not Always Mantle Cell Lymphoma!September 14, 2018Lymphoma & Plasma Cell Disorders
